References |
1 |
Simultaneous determination of a new anticancer drug galocitabine and its metabolites in blood by high-performance liquid chromatography
|
2 |
EUCRISA? (crisaborole) ointment, 2%, for topical use
|
3 |
A new, validated HPLC-MS/MS method for the simultaneous determination of the anti-cancer agent capecitabine and its metabolites: 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, 5-fluorouracil and 5-fluorodihydrouracil, in human plasma
|
4 |
Modified high-performance liquid chromatographic method for analysis of drotaverine in human plasma
|